Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Addict Med. 2020 Jul-Aug;14(4):319–325. doi: 10.1097/ADM.0000000000000608

Table 2:

Video directly observed therapy usage: percentage of days buprenorphine ingestion confirmed with videos (n=14)

Medication Adherence All Participants (n=14) Completed Per Protocol (n=12)*
Range Median (IQR) Mean (SD) Range Median (IQR) Mean (SD)
# of Days with a video submission 0–27 20.5 (14.0 – 24.0) 17.7 (8.5) 5–27 22.5 (17.8–24.0) 20.1 (6.4)
% of Days with a video submission 0–96.4% 73.2% (50.0, 85.7) 63.3% (30.4%) 17.9–96.4% 80.4% (63.4–85.7%) 71.7% (22.7%)
# of Days with self-reported dosing 4–28 27 (21.3, 28) 22.6 (8.0) 15–28 27 (25–28) 25.4 (4.1)
% of Days with self-reported dosing 14.3–100% 96.4% (75.9,100) 80.9% (28.6) 53.6–100% 96.4% (89.3–100%) 90.8 (14.5%)
*

Excludes one participant who was incarcerated for two weeks and one participant unable/unwilling to upload videos